1. Industry Perspective on Standardizing Food-Effect Studies for New Drug Development

   • Patrick J. Marroum
   • Silpa Nuthalapati
   • Walid M. Awni

   Current Opinion 19 February 2018 Pages: 901 - 909

   

2. Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics

   • Yash Gandhi
   • Timothy Eley
   • Tushar Garimella

   Review Article 20 January 2018 Pages: 911 - 928

   

3. Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease

   • Amy Hemperly
   • Niels Vande Casteele

   Review Article 12 January 2018 Pages: 929 - 942

   

4. Methods of Estimating Kidney Function for Drug Dosing in Special Populations

   • Laura A. Hart
   • Gail D. Anderson

   Review Article 22 January 2018 Pages: 943 - 976

5. Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials

   • Ben Klünder
   • Mohamed-Eslam F. Mohamed
   • Ahmed A. Othman

   Original Research Article Open access 26 October 2017 Pages: 977 - 988

   

6. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients

   • Piergiorgio Cojutti
   • Manjunath P. Pai
   • Federico Pea

   Original Research Article 28 October 2017 Pages: 989 - 1000

   

7. Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential

   • Marcus-Hillert Schultze-Mosgau
   • Joachim Höchel
   • Antje Rottmann

   Original Research Article Open access 12 January 2018 Pages: 1001 - 1015

   

8. Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis

   • Marc Burgard
   • Indy Sandaradura
   • Stefanie Hennig

   Original Research Article 13 November 2017 Pages: 1017 - 1027

   

9. Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease

   • Axel Facius
   • Eleonora Marostica
   • Gezim Lahu

   Original Research Article Open access 25 May 2018 Pages: 1029 - 1038

   

10. Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials

    • Sven C. van Dijkman
    • Nico C. B. de Jager
    • Oscar Della Pasqua

    Original Research Article 23 January 2018 Pages: 1039 - 1053

    

11. Correction to: Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials

    • Sven C. van Dijkman
    • Nico C. B. de Jager
    • Oscar Della Pasqua

    Correction 25 April 2018 Pages: 1055 - 1056

12. Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic

    • Elke Kleideiter
    • Chiara Piana
    • Michael Gautrois

    Correction Open access 13 June 2018 Pages: 1057 - 1058